D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$1.29B |
| 2 |
Apple
AAPL
|
+$1.22B |
| 3 |
T-Mobile US
TMUS
|
+$889M |
| 4 |
Micron Technology
MU
|
+$887M |
| 5 |
Netflix
NFLX
|
+$828M |
Top Sells
| 1 |
Robinhood
HOOD
|
+$1.02B |
| 2 |
GE Vernova
GEV
|
+$976M |
| 3 |
Charles Schwab
SCHW
|
+$582M |
| 4 |
TSMC
TSM
|
+$572M |
| 5 |
Microsoft
MSFT
|
+$564M |
Sector Composition
| 1 | Technology | 23.26% |
| 2 | Healthcare | 12.06% |
| 3 | Consumer Discretionary | 11.62% |
| 4 | Financials | 9.02% |
| 5 | Industrials | 9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
576
Altice USA
ATUS
$1.09B
| $23.8M | 0.02% |
11,130,938
-83,039
| -0.7% | -$178K |
|
577
Moog
MOG.A
$6.24B
| $23.8M | 0.02% |
131,598
+58,953
| +81% | +$10.7M |
|
578
Evolent Health
EVH
$1.07B
| $23.7M | 0.02% |
2,104,373
+225,373
| +12% | +$2.54M |
|
579
Canadian Imperial Bank of Commerce
CM
$73.3B
| $23.6M | 0.02% |
332,154
+259,271
| +356% | +$18.4M |
|
580
Alkermes
ALKS
$4.45B
| $23.5M | 0.02% |
820,096
+351,615
| +75% | +$10.1M |
|
581
Estee Lauder
EL
$31.5B
| $23.4M | 0.02% |
289,512
-283,214
| -49% | -$22.9M |
|
582
Atour Lifestyle Holdings
ATAT
$5.42B
| $23.4M | 0.02% |
718,347
+183,012
| +34% | +$5.95M |
|
583
Devon Energy
DVN
$22.5B
| $23.3M | 0.02% |
733,959
-85,498
| -10% | -$2.72M |
|
584
Vanguard Emerging Markets Government Bond ETF
VWOB
$4.6B
| $23.2M | 0.02% |
355,661
-113,800
| -24% | -$7.44M |
|
585
Warby Parker
WRBY
$3.29B
| $23.1M | 0.02% |
1,055,580
-723,283
| -41% | -$15.9M |
|
586
State Street
STT
$31.4B
| $23.1M | 0.02% |
217,652
-30,708
| -12% | -$3.27M |
|
587
Church & Dwight Co
CHD
$22.7B
| $23.1M | 0.02% |
240,598
+40,700
| +20% | +$3.91M |
|
588
Health Care Select Sector SPDR Fund
XLV
$34B
| $23.1M | 0.02% |
+171,536
| New | +$23.1M |
|
|
NAGE
589
Niagen Bioscience, Inc. Common Stock
NAGE
$766M
| $23.1M | 0.02% |
1,601,808
+318,018
| +25% | +$4.58M |
|
590
Ambev
ABEV
$35.2B
| $23M | 0.02% |
9,525,015
+6,301,204
| +195% | +$15.2M |
|
591
ICF International
ICFI
$1.77B
| $22.9M | 0.02% |
270,708
+89,098
| +49% | +$7.55M |
|
592
Prestige Consumer Healthcare
PBH
$3.2B
| $22.9M | 0.02% |
286,608
+89,415
| +45% | +$7.14M |
|
593
VanEck Semiconductor ETF
SMH
$28.4B
| $22.9M | 0.02% |
82,035
+14,482
| +21% | +$4.04M |
|
594
Steris
STE
$24B
| $22.9M | 0.02% |
95,156
-14,955
| -14% | -$3.59M |
|
595
fuboTV
FUBO
$1.35B
| $22.8M | 0.02% |
5,894,695
-6,255,433
| -51% | -$24.1M |
|
596
Pediatrix Medical
MD
$1.44B
| $22.6M | 0.02% |
1,577,762
-294,415
| -16% | -$4.22M |
|
597
Valmont Industries
VMI
$7.45B
| $22.5M | 0.02% |
68,747
-61,764
| -47% | -$20.2M |
|
598
MGIC Investment
MTG
$6.54B
| $22.4M | 0.02% |
805,391
+478,675
| +147% | +$13.3M |
|
599
Customers Bancorp
CUBI
$2.35B
| $22.4M | 0.02% |
381,264
-66,803
| -15% | -$3.92M |
|
600
Power Integrations
POWI
$2.5B
| $22.3M | 0.02% |
399,742
-69,803
| -15% | -$3.9M |
|